User profiles for Parul Patel
 | Dr. Parul PatelScientist/Engineer-G, Space Applications Centre, Indian Space Research Organization … Verified email at sac.isro.gov.in Cited by 1528 |
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority …
…, L Sloan, M St Clair, M Murray, SL Ford, J Mrus, P Patel… - The Lancet, 2017 - thelancet.com
Background Cabotegravir and rilpivirine are antiretroviral drugs in development as long-acting
injectable formulations. The LATTE-2 study evaluated long-acting cabotegravir plus …
injectable formulations. The LATTE-2 study evaluated long-acting cabotegravir plus …
Prevalence of ESR1 mutations in cell-free DNA and outcomes in metastatic breast cancer: a secondary analysis of the BOLERO-2 clinical trial
…, P Sung, A Samoila, D You, T Bhatt, P Patel… - JAMA …, 2016 - jamanetwork.com
Importance Estrogen receptor α (ESR1) mutations found in metastatic breast cancer (MBC)
promote ligand-independent receptor activation and resistance to estrogen-deprivation …
promote ligand-independent receptor activation and resistance to estrogen-deprivation …
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label …
…, Y Wang, KJ Hudson, V Chounta, A Cutrell, P Patel… - The Lancet, 2020 - thelancet.com
Background Phase 3 clinical studies showed non-inferiority of long-acting intramuscular
cabotegravir and rilpivirine dosed every 4 weeks to oral antiretroviral therapy. Important phase 2 …
cabotegravir and rilpivirine dosed every 4 weeks to oral antiretroviral therapy. Important phase 2 …
[HTML][HTML] Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression
…, YS Kim, SL Ford, CL Talarico, P Patel… - … England Journal of …, 2020 - Mass Medical Soc
Background Simplified regimens for the treatment of human immunodeficiency virus type 1 (HIV-1)
infection may increase patient satisfaction and facilitate adherence. Methods In this …
infection may increase patient satisfaction and facilitate adherence. Methods In this …
[HTML][HTML] Long-acting cabotegravir and rilpivirine after oral induction for HIV-1 infection
…, M St. Clair, H Crauwels, SL Ford, P Patel… - … England Journal of …, 2020 - Mass Medical Soc
Background Long-acting injectable regimens may simplify therapy for patients with human
immunodeficiency virus type 1 (HIV-1) infection. Methods We conducted a phase 3, …
immunodeficiency virus type 1 (HIV-1) infection. Methods We conducted a phase 3, …
Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment
KY Smith, P Patel, D Fine, N Bellos, L Sloan, P Lackey… - Aids, 2009 - journals.lww.com
Background: Abacavir sulfate/lamivudine (ABC/3TC) and tenofovir DF/emtricitabine (TDF/FTC)
are widely used nucleoside reverse transcriptase inhibitors for initial HIV-1 treatment. …
are widely used nucleoside reverse transcriptase inhibitors for initial HIV-1 treatment. …
Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a …
…, KJ Hudson, BS Stancil, SL Ford, P Patel… - The lancet HIV, 2017 - thelancet.com
Background Cabotegravir (GSK1265744) is an HIV-1 integrase strand transfer inhibitor with
potent antiviral activity and a long half-life when administered by injection that prevented …
potent antiviral activity and a long half-life when administered by injection that prevented …
Genomic biomarkers of a randomized trial comparing first-line everolimus and sunitinib in patients with metastatic renal cell carcinoma
…, KH Huberman, U Bhanot, MS Chevinsky, P Patel… - European urology, 2017 - Elsevier
Background Metastatic renal cell carcinoma (RCC) patients are commonly treated with vascular
endothelial growth factor (VEGF) inhibitors or mammalian target of rapamycin inhibitors. …
endothelial growth factor (VEGF) inhibitors or mammalian target of rapamycin inhibitors. …
A randomised, prospective study to investigate the efficacy of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linkage to halt the progression of keratoconus
DPS O'Brart, E Chan, K Samaras, P Patel… - British Journal of …, 2011 - bjo.bmj.com
Aims A blind, randomised, prospective, bilateral study to investigate the efficacy of riboflavin/ultraviolet
A corneal collagen cross-linkage to halt the progression of keratoconus. Methods …
A corneal collagen cross-linkage to halt the progression of keratoconus. Methods …
Large-area soil moisture estimation using multi-incidence-angle RADARSAT-1 SAR data
The sensitivity of synthetic aperture radar (SAR) backscatter to soil moisture has been
adequately established. However, monitoring of soil moisture over large agricultural areas is still …
adequately established. However, monitoring of soil moisture over large agricultural areas is still …